Citigroup Inc Semler Scientific, Inc. Transaction History

Citigroup Inc

$190 Billion
Q1 2025

A detailed history of Citigroup Inc transactions in Semler Scientific, Inc. stock. As of the latest transaction made, Citigroup Inc holds 4,836 shares of SMLR stock, worth $199,291. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,836

Previous 7,652 36.8%

Holding current value

$199,291

Previous $413,000 57.63%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	SELL	$32.62 - $64.94 $91,857 - $182,871	-2,816 Reduced 36.8%	4,836 $175,000
Q4 2024 Feb 12, 2025	SELL	$22.48 - $74.73 $11,644 - $38,710	-518 Reduced 6.34%	7,652 $413,000
Q3 2024 Nov 12, 2024	BUY	$22.3 - $36.21 $64,625 - $104,936	2,898 Added 54.97%	8,170 $192,000
Q2 2024 Aug 12, 2024	BUY	$21.03 - $40.57 $34,447 - $66,453	1,638 Added 45.07%	5,272 $181,000
Q1 2024 May 10, 2024	BUY	$28.42 - $51.54 $83,696 - $151,785	2,945 Added 427.43%	3,634 $106,000
Q4 2023 Feb 09, 2024	BUY	$25.66 - $46.29 $17,089 - $30,829	666 Added 2895.65%	689 $30,000
Q3 2023 Nov 09, 2023	SELL	$23.15 - $28.54 $33,891 - $41,782	-1,464 Reduced 98.45%	23 $0
Q2 2023 Aug 10, 2023	BUY	$22.5 - $30.58 $33,457 - $45,472	1,487 New	1,487 $39,000
Q4 2022 Feb 09, 2023	BUY	$28.01 - $43.49 $516,868 - $802,520	18,453 Added 4232.34%	18,889 $623,000
Q3 2022 Nov 10, 2022	BUY	$27.75 - $45.8 $10,961 - $18,091	395 Added 963.41%	436 $16,000
Q2 2022 Aug 10, 2022	SELL	$27.86 - $50.32 $304,955 - $550,802	-10,946 Reduced 99.63%	41 $1,000
Q1 2022 May 12, 2022	BUY	$42.24 - $93.25 $163,553 - $361,064	3,872 Added 54.42%	10,987 $545,000
Q4 2021 Feb 10, 2022	BUY	$89.61 - $149.99 $637,575 - $1.07 Million	7,115 New	7,115 $652,000

Others Institutions Holding SMLR

# of Institutions

140

Shares Held

6.76M

Call Options Held

256K

Put Options Held

123K

View Full List

About Semler Scientific, Inc.

Ticker SMLR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 6,800,580
Market Cap $280M
Description
Semler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's va...

More about SMLR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.

Account